TUDOR INVESTMENT CORP ET AL - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$588
+44.5%
151,235
+26.3%
0.01%
+12.5%
Q4 2022$407
-99.9%
119,755
+99.4%
0.01%
+14.3%
Q3 2022$328,000
+33.3%
60,064
+10.2%
0.01%
+16.7%
Q2 2022$246,000
-81.7%
54,513
-73.9%
0.01%
-72.7%
Q4 2021$1,341,000
+19.4%
208,526
+8.1%
0.02%
+22.2%
Q3 2021$1,123,000
+34.7%
192,931
+138.9%
0.02%
+12.5%
Q2 2021$834,000
-4.9%
80,772
-3.1%
0.02%
-11.1%
Q1 2021$877,000
+85.4%
83,372
+157.2%
0.02%
-14.3%
Q3 2020$473,000
-54.2%
32,418
-39.8%
0.02%
-54.3%
Q4 2019$1,032,000
+533.1%
53,859
+343.0%
0.05%
+820.0%
Q1 2018$163,000
-25.6%
12,157
-46.8%
0.01%
-16.7%
Q4 2017$219,000
+10.6%
22,836
+26.3%
0.01%
+20.0%
Q3 2017$198,000
+45.6%
18,075
+19.9%
0.01%
+25.0%
Q2 2017$136,000
+24.8%
15,078
+29.7%
0.00%
+33.3%
Q4 2016$109,000
-31.4%
11,624
-28.7%
0.00%
-25.0%
Q3 2016$159,000
-77.2%
16,313
+8.8%
0.00%
-85.2%
Q2 2014$698,00015,0000.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders